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Chronic T cell activation and accelerated immune senescence are hallmarks of HIV
infection, which may contribute to the increased risk of cardiometabolic diseases
in people living with HIV (PLWH). T lymphocytes play a central role in modulating
adipose tissue inflammation and, by extension, adipocyte energy storage and release.
Here, we assessed the CD4+ and CD8+ T cell profiles in the subcutaneous adipose
tissue (SAT) and blood of non-diabetic (n = 9; fasting blood glucose [FBG] < 100
mg/dL), pre-diabetic (n = 8; FBG = 100–125 mg/dL) and diabetic (n = 9; FBG
≥ 126 mg/dL) PLWH, in addition to non- and pre-diabetic, HIV-negative controls
(n = 8). SAT was collected by liposuction and T cells were extracted by collagenase
digestion. The proportion of naïve (TNai) CD45RO
−CCR7+, effector memory (TEM)
CD45RO+CCR7−, central memory (TCM) CD45RO
+CCR7+, and effector memory
revertant RA+(TEMRA) CD45RO
−CCR7− CD4+ and CD8+ T cells were measured by flow
cytometry. CD4+ and CD8+ TEM and TEMRA were significantly enriched in SAT of PLWH
compared to blood. The proportions of SAT CD4+ and CD8+ memory subsets were
similar across metabolic status categories in the PLWH, but CD4+ T cell expression
of the CD69 early-activation and tissue residence marker, particularly on TEM cells,
increased with progressive glucose intolerance. Use of t-distributed Stochastic Neighbor
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Embedding (t-SNE) identified a separate group of predominantly CD69lo TEM and TEMRA
cells co-expressing CD57, CX3CR1, and GPR56, which were significantly greater in
diabetics compared to non-diabetics. Expression of the CX3CR1 and GPR56 markers
indicate these TEM and TEMRA cells may have anti-viral specificity. Compared to HIV-
negative controls, SAT from PLWH had an increased CD8:CD4 ratio, but the distribution
of CD4+ and CD8+ memory subsets was similar irrespective of HIV status. Finally,
whole adipose tissue from PLWH had significantly higher expression of TLR2, TLR8,
and multiple chemokines potentially relevant to immune cell homing compared to
HIV-negative controls with similar glucose tolerance.
Keywords: HIV—human immunodeficiency virus, adipose tissue, diabetes mellitus, TEMRA, T effector memory
cells, GPR56, CX3CR1, memory T cells
INTRODUCTION
People living with human immunodeficiency virus (HIV) are
at an increased risk of developing insulin resistance and overt
diabetes mellitus, but the factors contributing to the high
prevalence of metabolic disease in the HIV population are
not fully understood (1–3). Since HIV was identified as the
cause of acquired immune deficiency syndrome (AIDS) in the
early 1980s, the metabolic consequences of altered adipose
tissue function in people living with HIV (PLWH) have been
a major research focus (4). Early studies identified accelerated
lipolysis and hepatic lipogenesis as central energy metabolism
abnormalities in untreated HIV infection (5–7), while early-
generation nucleoside reverse transcriptase inhibitors (NRTIs)
caused adipocyte mitochondrial damage and adipose tissue
fibrosis (8–12), and treatment with early protease inhibitors
was accompanied by accumulation of visceral adipose tissue
(VAT), hyperlipidemia, and insulin resistance (13–16). More
recently, several studies describe profound changes in adipose
tissue T cell populations during chronic HIV and simian
immunodeficiency virus (SIV; a non-human primate virus
similar to HIV) infections, which may influence adipose tissue
metabolic function. These include changes in T cell surface
marker phenotypes, cytokine production, antigen receptor
repertoire, and capacity for latent infection with HIV or SIV
provirus (17–22). Notably, several studies found that HIV and
SIVwere accompanied by a substantial increase in the proportion
of adipose CD8+ T cells relative to CD4+ T cells, which
is strikingly similar to the enrichment in CD8+ T cells also
described in obesity (23–25).
Adipose tissue is a complex and vascularized cellular
amalgam, comprised of multipotent adipocyte progenitors,
mature adipocytes, fibroblasts, and immune cells of the
adaptive and innate lineages. A diverse group of immune
cells collectively identify and eliminate the range of viruses
and other pathogens which can infiltrate adipose tissue, and
these processes impact local levels of pro-inflammatory and
other cytokines with subsequent effects on adipocyte regulation
and energy storage and release. T lymphocytes play several
beneficial and detrimental roles within this environment. Studies
of obese humans and animals demonstrate an increase in
adipose tissue CD8+ T cells and CD4+ TH1 cells, a decrease
in T regulatory cells, and an increase in M1-phenotype
(CD68+, tumor necrosis factor-α [TNF-α], interleukin [IL]-6,
IL-12, and IL-23-producing) pro-inflammatory macrophages
(23, 24, 26, 27) compared to non-obese controls. In animal
models of obesity, the infiltration of CD8+ T cells into
adipose tissue precedes the recruitment of macrophages
(23); and the resulting increase in local IL-6, TNF-α and
other inflammatory mediators act on adipocyte surface
receptors and other mechanisms to inhibit insulin signaling via
reduced insulin receptor substrate-1 (IRS-1), phosphoinositide
3-kinase p85α, and glucose transporter type 4 (GLUT4)
expression (17, 18, 23, 28–32).
The increase in the CD8+ to CD4+ T cell ratio observed in
HIV infection is like that seen in diet-induced obesity, though
the mechanisms underlying the accumulation of CD8+ T cells
in the adipose tissue of PLWH are not well-defined. Studies
in macaques suggest that the high proportion of CD8+ T
cells is not due to depletion of CD4+ T cells (18). Although
lack of Ki-67 expression in adipose tissue T cells has been
interpreted as lack of evidence for in situ proliferation, greater
CD8+ TCR clonality in subcutaneous adipose tissue (SAT)
implies antigen specificity might drive the increase rather than
stochastic recruitment of circulating CD8+ T cells. This is
further supported by the finding that CD8+ and CD4+ T cells
in adipose tissue predominantly display a memory phenotype
with increased levels of CD69 expression compared to those in
blood (17, 18).
While prior studies have shown enrichment of CD8+ over
CD4+ T cells in adipose tissue after HIV infection, there is a
paucity of data on whether a particular subset of cells underlies
this change, and whether adipose tissue T cell profiles differ
according to insulin sensitivity in PLWH (as might be expected
given prior findings in obesity-related insulin resistance). In this
study, we hypothesized that the enrichment of CD8+ T cells
in the adipose tissue of PLWH could be attributed to an over-
representation of one or a few memory cell subtypes, and that
greater CD8+ and CD4+ T cell activation would characterize
the adipose tissue of diabetic PLWH. We evaluated SAT CD4+
and CD8+ T cell subsets (including naïve cells, activated cells,
and central memory [TCM], effector memory [TEM], and effector
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memory revertant RA+ [TEMRA] cells) in PLWH vs. HIV-
negative controls, and among diabetic vs. non-diabetic PLWH.
MATERIALS AND METHODS
Study Participants
We enrolled 26 PLWH on long-term antiretroviral therapy
(ART) with sustained virologic suppression from the Vanderbilt
Comprehensive Care Clinic between August 2017 and June
2018. Hemoglobin A1c (HbA1c) and fasting blood glucose
(FBG) were used to classify participants as non-diabetic (n = 9;
HbA1c < 5.7% and FBG < 100 mg/dL), pre-diabetic (n = 8;
HbA1c 5.7–6.5% and/or FBG 100–125 mg/dL), and diabetic
(n = 9; HbA1c ≥ 6.5% and/or FBG ≥ 126 mg/dL, and on anti-
diabetes medications). A group of 8 HIV-negative, non- and
pre-diabetic controls were enrolled from the community. The
PLWHwere on ART for at least 18 months, had HIV-1 RNA<50
copies/ml for the prior 12 months, CD4+ count >350 cells/µl,
and had no known inflammatory or rheumatologic conditions.
We excluded persons with self-reported heavy alcohol use
(defined as >11 drinks/week), any cocaine/amphetamine use,
and those receiving corticosteroids or growth hormone.
All visits occurred in the Vanderbilt Comprehensive Care
Clinic research suite or the Vanderbilt Clinical Research Center
between 8 and 11 am. Participants fasted for a minimum of
8 h prior to blood collection for laboratory measurements and
peripheral blood mononuclear cell (PBMC) separation (PLWH
only). Blood glucose, HbA1c, high-sensitivity C-reactive protein
(hsCRP), low-density lipoprotein (LDL), triglycerides, and high-
density lipoprotein (HDL) were measured in the fasting blood
samples at the Vanderbilt Clinical Chemistry Laboratory.
Adipose Tissue Biopsy and T Cell
Extraction
SAT biopsies were collected ∼3 cm to the right of the umbilicus
after anesthetizing the skin with lidocaine and infiltrating 40ml
of sterile saline and lidocaine into the subcutaneous adipose
tissue as tumescent fluid.We collected∼5 grams of adipose tissue
using a 2.1mm blunt, side-ported liposuction catheter (Tulip
CellFriendlyTM GEMS system Miller Harvester, Tulip Medical
Products) designed for the extraction of viable adipocytes and
stromal vascular cells during cosmetic adipose tissue transfer
procedures (33). With this approach, adipose tissue is recovered
in droplets generally <3mm in diameter, limiting the need to
mechanically mince the sample, and the tissue is placed in 40–
50 cc of cold saline and mixed to rinse. Any visible clots are
removed before the sample is transferred to a 70µm mesh filter
for repeated saline rinses with constant stirring. The adipose
tissue is then placed in a gentleMACSTM Dissociator (Miltenyi
Biotec) followed by incubation with collagenase (Roche Catalog
#11088866001). Mononuclear cells were separated by Ficoll-
Paque Plus density gradient and cryopreserved in fetal bovine
serum (FBS) with 10% DMSO.
Flow Cytometry Analysis
PBMC and SAT mononuclear cell aliquots were processed
and stained as previously published (21). In brief, matched
cryopreserved PBMCs and SAT cells were quickly thawed at
37◦C and suspended in R10 media (RPMI with 10% FBS).
These were then washed once in phosphate buffered saline (PBS)
and stained with multiple fluorescent tagged antibodies: CD3-
BV786 (Clone SK7; BD Biosciences #563800), CD4-PcPCy5.5
(Clone RPA-T4; BD Biosciences #560650), CD8-A700 (Clone
PRA-T8; BD Biosciences #557945), CD57-FITC (Lot 4182924;
BD Pharmingen # 555619), CX3CR1-PE (Clone 2A9-1; BD
Biosciences #565796), CD45RO-PECF594 (Clone UCHL1; BD
Biosciences #562299), CD14-V500 (CloneM5E2, BD Biosciences
#561391), CD19-V500 (Clone HIB19; BD Biosciences #561121),
LIVE/DEAD Fixable Aqua (ThermoFisher; L34957), CD69-APC
(Clone FN50; BD Biosciences #560711), CCR7-V450 (Clone
150503; BD Biosciences #562555), GPR56-PECy7 (Clone CG4;
BioLegend #358205), and HLA-DR APC Cy7 (Clone G46.6;
BD Biosciences #561358). CCR7 and CX3CR1 antibody stains
were performed at 37◦C; the remainder was stained at room
temperature. Cells were analyzed on a 4-laser FACSAria III
(all samples from PLWH) or 5-laser LSRII (HIV-negative SAT
samples) (BD Biosciences, San Jose, CA). Bead calibration was
used to standardize runs done on different days. Flow cytometry
data were analyzed using FlowJo software (version 10.4.1) and
Cytobank (version 6.3.1) (34, 35).
The T cell memory populations in our study are
defined as naive T cells (TNai, CD45RO
−CCR7+), T
effector memory (TEM, CD45RO
+CCR7−), T central
memory (TCM, CD45RO
+CCR7+), and T effector memory
revertant/re-expressing CD45-RA (TEMRA, CD45RO
−CCR7−).
Representative gating strategies in Supplementary Figure 1
and Figure 1 show the phenotypic markers used to define the
memory subsets (CD45RO and CCR7). Total memory cells are a
combined group consisting of TEM, TCM, and TEMRA.
Adipose Tissue Gene Expression
Adipose tissue was rinsed, placed in cryovials and snap-frozen
in liquid nitrogen immediately after collection for subsequent
mRNA expression assays. mRNA was extracted after mechanical
lysis with the Qiagen RNeasy Lipid Tissue Kit. We used
the Nanostring nCounter Plex2 human inflammation panel
to quantify mRNA expression of over 250 genes spanning a
broad range of relevant immune pathways including interleukin
signaling, Ras, T-cell markers, and Toll-like receptor signaling.
Adipose tissue mRNA expression levels were normalized using
14 synthetic spike-ins (6 positive controls and 8 negative
controls) and 6 cellular housekeeping genes included in the assay
(GAPDH, GUSB, HPRT1, PGK1, TUBB, and CLTC). We first
calculated the coefficient of variation (CV) for the control genes.
The CV of the positive controls is proportional to the technical
variability introduced by the nCounter platform. The CV for
the housekeeping controls is proportional to the confounding
biological variation due to sample input. The mean endogenous
CV shows the global noise of experimentally observed genes.
After evaluating different normalization approaches based on
CV values, we developed a normalization strategy including the
following steps. First the background count levels were calculated
using the mean of negative controls, then subtracted from each
sample. The normalization factor for sample/RNA content was
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FIGURE 1 | Subcutaneous adipose tissue from PLWH has a higher percentage of CD4+ and CD8+ memory T cells compared to matched blood samples. (A)
Frequencies of total CD4+ and CD8+ T cells (percentage of CD3+ cells) in subcutaneous adipose tissue (SAT) and blood (PBMC) from all 26 PLWH. (B)
Representative plot showing gating of CD4+ memory T cells (gated on CD3+) in SAT and PBMC depicted by the yellow and red shading, respectively; on the right are
individual values and means. (C) Representative plot showing total CD8+ memory T cells in adipose tissue and PBMC. The box and whiskers plot indicate mean ±
SD. Wilcoxon matched pair signed test was used to calculate statistics (A-C); ****p < 0.0001.
calculated using the geometric mean of a set of pre-specified
annotated housekeeping genes. The algorithm normalizes for
sample or RNA content, i.e., “pipetting” fluctuations, using
the geometric mean of pre-specified annotated housekeeping
genes. The count data were then divided by the normalization
factor to generate counts normalized to the geometric mean of
housekeeping genes. None of the housekeeping genes differed
significantly in their distribution between study groups.
Statistical Analyses
For comparisons, PLWH were grouped according to metabolic
status as non-diabetic (n = 9), pre-diabetic (n = 8), and diabetic
(n = 9). The 8 HIV-negative controls were matched to 9 PLWH
with similar HbA1c and body mass index (BMI) values to
yield a similar comparison group (one control was matched
to two PLWH). Percentages of CD4+ and CD8+ subsets were
compared between paired blood and adipose tissue samples
using Wilcoxon signed-rank tests for paired data. Differences
between the PLWH metabolic groups, and between HIV-
negative controls and the PLWH, were calculated using Mann-
Whitney and Kruskal Wallace tests. When significant between-
group comparisons were noted among the PLWH, univariable
and multivariable linear regression were used to assess the
relationship of cellular populations with progressive glucose
intolerance. Statistical analyses and graphs were performed using
SPSS (IBM, Armonk, NY), R (www.r-project.org), and GraphPad
Prism 7 (GraphPad Software, La Jolla, CA),
Adipose tissue genes were grouped according to immune
system pathways specified in the NanoString kit, and normalized
mRNA levels were compared between the PLWH and HIV-
negative participants. DEseq2 was used to detect differential
expression between two groups based on the normalized
count data, taking into account technical and biological
variability (36, 37). Differences in gene expression were
calculated as fold-changes, and p-values were adjusted for
multiple comparisons using the Benjamini-Hochberg procedure.
Analyses were performed using R. Volcano plots displaying the
NanoString data were generated using XL-STAT.
RESULTS
Clinical and Demographic Characteristics
of PLWH and HIV-Negative Subjects
The non-diabetic (n = 9), pre-diabetic (n = 8), and diabetic
(n = 9) groups of PLWH are compared in Table 1. Age,
race and sex were similar across the groups, as were CD4+
nadir, duration of ART, and the proportions receiving
integrase inhibitor-based regimens (p > 0.05 for all
comparisons). BMI and waist circumference increased with
progressive glucose intolerance (p = 0.04 for both). The
HIV-negative controls (n = 8) and comparator PLWH (9
out of 26 total) were similar in age, BMI, and HbA1c values
(p > 0.05 for all), though the controls were more likely to
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TABLE 1 | Cohort demographic and clinical characteristics according to glucose tolerance.
Variable HIV (+) Non-diabetic




FG = 100–125 mg/dL
(n = 8)




Age, median yr (IQR) 39 (38, 49) 59 (33, 63) 54 (45, 61) 0.22
Female (%) 1 (11%) 2 (25%) 4 (44%) 0.23
Caucasian race (%) 4 (40%) 4 (50%) 3 (33%) 0.78
BMI, kg/m2 30.8 (27.8, 36.4) 32.7 (30.8, 37.7) 40.2 (34.0, 51.9) 0.04
Waist: hip ratio 0.97 (0.92, 1.00) 0.97 (0.92, 1.04) 0.98 (0.96, 1.09) 0.60
Waist Circumference, cm 106 (101, 114.5) 107 (101, 111) 116 (110, 142) 0.04
GLUCOSE METABOLISM MEASUREMENTS
Hemoglobin A1c, % 5.3 (5.1, 5.4) 5.6 (4.9, 5.9) 7.2 (6.1, 9.8) <0.001
Fasting glucose, mg/dL 87 (75, 96) 116 (102, 122) 141 (120, 238) <0.001
PLASMA LIPIDS
Cholesterol, mg/dL 181 (149, 194) 185 (172, 210) 175 (143, 193) 0.28
LDL, mg/dL 95 (77, 109) 116 (96, 131) 82 (56, 107) 0.05
Fasting HDL, mg/dL 52 (39, 81) 38 (34, 56) 43 (35, 56) 0.31
Fasting TG, mg/dL 104 (61, 173) 196 (82, 257) 149 (114, 267) 0.37
IMMUNE MARKERS
High sensitive C-reactive protein, mg/dl 2.7 (1.1, 8.4) 3.1 (0.9, 4.2) 3.1 (1.9, 9.8) 0.67
CD4 at study visit 803 (767, 1065) 702 (643, 942) 1056 (950, 1167) 0.02
CD4 at start of therapy 482 (364, 617) 448 (154, 567) 323 (173, 432) 0.12
CD4:CD8 ratio 1.07 (0.88, 1.43) 1.04 (0.73, 1.18) 1.36 (0.94, 1.52) 0.49
ANTIRETROVIRAL THERAPY HISTORY
Exposure to AZT, n (%) 2 (22%) 3 (38%) 5 (56%) 0.35
Duration of ART therapy, yr 7.5 (4.0, 13.2) 11.8 (5.8, 18.9) 11.6 (5.4, 18.6) 0.56
Integrase inhibitor-based therapy 8 (89%) 4 (40%) 7 (78%) 0.18
OTHER
Smoker (%) 2 (22%) 2 (25%) 2 (22%) 0.99
Hepatitis C (%) 1 (11%) 0 (0%) 2 (22%) 0.36
ART, antiretrovirals; AZT, azidothymidine; BMI, body mass index; FG, fasting glucose; HDL, high-density lipoproteins; IQR, interquartile range; LDL, low-density lipoproteins; TG,
triglycerides; yr, year.
The bolded values are p-values <0.05, indicating statistical significance.
be female and white (Table 2). Bold values in Tables 1, 2
indicate p < 0.05.
Adipose Tissue From PLWH Is Enriched in
Memory CD8+ and CD4+ T Cells
We found no difference in the percentage of total CD8+ and
CD4+ T cells (gated on CD3+ T cells) between SAT and
peripheral blood from PLWH Figure 1A. We also observed, as
previously described by other groups, a higher percentage of
total CD4+ memory T cells (Figure 1B) and CD8+ memory
T cells (Figure 1C) in SAT compared to peripheral blood
(p < 0.0001) (17).
SAT From PLWH Is Enriched in CD4+ and
CD8+ TEM and TEMRA Cells Compared to
Blood
Despite the growing body of literature on adipose tissue immune
cells, the distribution of memory T cell subsets in adipose tissue
from PLWH has not been characterized, and the role of memory







Age, median years (IQR) 39 (38, 49) 49 (37, 62) 0.32
Female (%) 1 (10%) 5 (63) 0.02
Caucasian race (%) 4 (40%) 8 (100%) <0.01
BMI, kg/m2 30.8 (27.8, 36.4) 39.35 (33.3, 48.4) 0.89
GLUCOSE METABOLISM MEASUREMENTS
Hemoglobin A1c, % 5.3 (5.15, 5.4) 5.7 (5.4, 5.9) 0.84
The bolded values are p-values <0.05, indicating statistical significance.
T cell subsets within tissue compartments in general is not well-
understood. A prior study assessed the distribution of CD4+
and CD8+ TNai, TEM, TCM, and TEMRA subsets in lung, spleen,
colon, ileum, jejunum, and lymph nodes, but not adipose tissue,
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from healthy donors, and found that CD4+ TNai, TEM, and
TCM proportions in lung and pulmonary and mesenteric lymph
nodes were similar to the proportion in blood, while jejunum,
ileum, and colon were roughly 3- to 4-fold enriched in TEM
(38). In all tissues, CD4+ TEMRA were relatively sparse (<10%).
In contrast, ∼30% of CD8+ T cells in blood, spleen, and lung
had a TEMRA phenotype, while the CD8
+ T cells in jejunum,
ileum, and colon were overwhelmingly TEM (38). A subsequent
study in the adipose tissue of mice found approximately equal
proportions of CD4+ TEM and CD4
+ TRM cells (a “resident
memory” phenotype defined by the authors as CD69 expression
on TEM cells) in adipose tissue samples, and fewer TCM (39).
However, CD8+ memory cells were predominantly TRM in SAT,
with similar, lower proportions of TEM and TCM. The same study
looked at mesenteric adipose tissue in macaques and again found
high levels of CD8+ TRM, while CD4
+ cells were primarily TNai
and TCM, with low levels (<10%) of TEM and TRM, potentially
highlighting important differences between species.
We first assessed CD4+ and CD8+ memory subsets in SAT
and blood from all 26 PLWH. Multiparameter gates were used
to quantify memory CD4+ and CD8+ T cells within each
sample as shown in Supplementary Figures 1, 9. Each sample
had >100,000 ungated cells (Supplementary Figures 10A–C).
SAT was significantly enriched in CD4+ and CD8+ TEM
and TEMRA cells (Figures 2A,B) compared to blood but had
fewer TNai and TCM cells. We then compared the average
TNai, TCM, TEM, and TEMRA fractions within SAT and blood
among the 26 PLWH (Supplementary Figure 2). We found
that CD4+ T cells in SAT can be ranked by frequency as
TEM > TCM > TNai > TEMRA, whereas peripheral blood contains
CD4+ TCM > TNai > TEM > TEMRA. In contrast, SAT CD8
+ T
cells are primarily TEMRA followed by TEM.
The Relative Distribution of SAT Memory T
Cell Subsets Does Not Differ With
Metabolic Status in PLWH
The study of adipose tissue T cells in mice by Han et al. also
found that recall responses of adipose tissue memory T cells
were enhanced after antigen re-challenge, with downregulation
of several metabolic pathways in whole adipose tissue (including
lipid biosynthesis and cholesterol and long-chain fatty-acyl-
CoA metabolic processes) and a detectable reduction in serum
levels of adiponectin and cholesterol (39). These findings
suggest a possible mechanism by which the accumulation, and
subsequent stimulation, of memory cells in adipose may disrupt
metabolic homeostasis.
In light of prior animal studies indicating a potential
contribution of effector memory T cells to inflammation and
impaired metabolic function in adipose tissue, we sought to
characterize the distribution of SAT memory T cell subsets in
PLWH to determine if there were clear differences between
non-diabetics, pre-diabetics, and diabetics in the relative
proportions of TNai, TCM, TEM, and TEMRA cells. We utilized t-
distributed Stochastic Neighbor Embedding (t-SNE) to visualize
groups of adipose tissue and blood CD4+ and CD8+ T
cell populations based on 12-color flow cytometry staining.
Supplementary Figure 3 shows the distribution of TNai, TCM,
TEM, and TEMRA cells in CD4
+ and CD8+ T cells in the adipose
tissue and blood from four representative non-diabetic and
diabetic PLWH. The plots showed fewer TNai cells and enriched
CD4+ and CD8+ TEM and TEMRA cell fractions in the SAT
compared to the matched peripheral blood.
The t-SNE findings were congruous with our results from
2-dimensional flow cytometry gating. For CD4+ T cells, the
proportion of TNai and TCM cells were significantly lower
compared to blood in all three groups, while the proportion
of TEM and TEMRA cells was significantly higher (Figure 3A).
However, none of the adipose memory subsets in the pre-
diabetics or diabetics were significantly different from the non-
diabetics in pairwise comparisons. There was less consistency in
the relative proportions of CD8+ memory cells in the blood and
adipose tissue. While CD8+ TNai and TCM cells were significantly
lower in the SAT in all three groups (Figure 3B), SAT CD8+
TEM cells were only significantly higher compared to blood in
the diabetics, and SAT TEMRA cells were only significantly higher
in the non- and pre-diabetic groups. In summary, these findings
suggest that while adipose tissue is enriched in CD4+ and CD8+
TEM and TEMRA cells compared to blood, the relative distribution
of naïve and memory T cells within SAT does not markedly vary
by metabolic status in PLWH.
Next, we assessed SAT memory T cells according to BMI
category and age (Supplementary Figures 4, 5). We observed no
significant differences in SAT CD4+ and CD8+ memory T cell
populations according to BMI status. When we compared naïve
and memory T cell subsets by age, we found the proportion of
CD4+ TNai cells in SAT from PLWH <35 years (34% of total
CD4+ cells) was significantly higher than in older subjects 35–
55 years (12%, p < 0.05) and those >55 years (16%, p < 0.01).
The relative reduction in CD4+ TNai cells appeared principally
due to an increase in the proportions of TEM cells at higher ages;
TEM cells constituted 29% of total CD4
+ cells in participants
<35 years, but rose to 50% in those 35–55 years (p = 0.06) and
47% in those >55 years (p < 0.01). These differences were less
pronounced for CD8+ T cells; the TEM proportion in PLWH>55
years was significantly higher than those<35 years (38% vs. 22%,
p< 0.05), but the difference was not significant for those ages 35–
55. Our findings were similar to a prior study of health donors,
which found the proportion of total CD4+ memory (CD45RO+)
T cells in lung and mesenteric lymph nodes, spleen, ileum and
colon also rose with increasing age (38).
CD4+ T Cell CD69 Expression Increases
With Progressive Glucose Intolerance
in PLWH
CD69 is an inducible, early-activation indicator which also serves
as a putative tissue-resident marker onmemory T cells in human,
as well as in animal, mucosal and lymphoid tissues (38, 40, 41),
but is largely absent on memory T cells in blood (38). CD69 has
been used as a marker of adipose tissue resident memory cells
in animals (39), including in SIV-infected macaques (18), as well
as in prior studies of PLWH (17, 19). At present, there are few
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FIGURE 2 | Subcutaneous adipose tissue has a higher percentage of TEM (CD45RO
+ CCR7−) and TEMRA (CD45RO
− CCR7−) cells compared to blood in PLWH.
(A) The bar graphs show frequencies of CD4+ TNai, TEM, TCM, and TEMRA cells in subcutaneous adipose tissue (SAT) and blood (PBMC) from all twenty-six
subjects. (B) Frequencies of CD8+ TNai, TEM, TCM, and TEMRA cells in SAT and PBMC. The numbers in the bar graphs on the left indicate mean and diagonal lines
indicate matched pairs of SAT and PBMCs. Wilcoxon matched pair signed test was used to calculate statistics ****p < 0.0001; ***p < 0.001.
FIGURE 3 | Analysis of CD4+ and CD8+ memory subsets by metabolic status in PLWH. (A) The bar graphs on the top row show frequencies of CD4+ TNai, TEM,
TCM, and TEMRA cells in subcutaneous adipose tissue (SAT) and blood (PBMC) from all twenty six PLWH. Participants are grouped based on glucose tolerance:
non-diabetic (Non-DM): hemoglobin A1c < 5.7% and fasting glucose < 100 mg/dL (n = 9); Pre-DM: hemoglobin A1c 5.7–6.4% or fasting glucose 100–125 mg/dL
(n = 8); DM: hemoglobin A1c > 6.5% and/or fasting glucose > 126 mg/dL, and on anti-diabetes medication (n = 9). (B) Frequencies of CD8+ TNai, TEM, TCM, and
TEMRA cells in SAT and PBMC. The box and whiskers plot indicate mean ± SD. Wilcoxon matched pair signed test was used to calculate statistics between matched
PBMC and SAT T cells, Mann-Whitney test was used to analyze differences in SAT and PBMC T cell subsets between metabolic groups; **p < 0.01, *p < 0.05.
studies on CD69 expression on adipose tissue T cells in PLWH,
none of which has looked at their link with metabolic status.
We measured CD69 expression on memory T cell
subsets in SAT and blood (gating strategy shown in
Supplementary Figure 6). As reported in prior studies of
PLWH, CD69 expression was present on CD4+ T cell subsets
from SAT but almost absent in peripheral blood (Figure 4)
(17, 19), whereas CD69 expression on CD8+ T cells from SAT
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FIGURE 4 | CD69 expression on subcutaneous adipose tissue CD4+ T cells increases with progressive glucose intolerance. (A–E) Frequencies of CD4+ total T cells,
TNai, TCM, TEM, and TEMRA cells expressing the CD69 activation and putative tissue-residence marker in subcutaneous adipose tissue (SAT) and blood (PBMC). The
box and whiskers plot indicate mean ± SD. Wilcoxon matched-pair rank test was used to calculate differences between PBMC and SAT. Mann-Whitney test used to
calculate differences between groups; blue lines and red * depict differences between groups **p < 0.01, *p < 0.05.
and blood was similar (Supplementary Figure 11A). While we
observed the relative proportions of SAT CD4+ and CD8+ TCM,
TEM, and TEMRA cells to be similar regardless of metabolic status
in PLWH (Figure 3), expression of CD69 on CD4+ T cells rose
with progressive glucose intolerance in a step-wise progression
from non-diabetic, to pre-diabetic, to diabetic. Compared to
non-diabetics, diabetic PLWH had significantly higher CD69
expression on total CD4+ T cells, TCM, and TEM (p < 0.01 for all
three), as well as TNai and TEMRA (p < 0.05 for both, Figure 4).
Similarly, the pre-diabetics also had higher CD69 expression on
SAT total CD4+ T cells and TNai, TEM, and TEMRA (p < 0.05 for
all) compared to non-diabetics, but not on TCM (p < 0.07). In
contrast, we did not observe any significant differences in CD69
expression on CD8+ T cells according to metabolic status.
Given the stepwise progression of CD69 expression on
CD4+ T cell subsets with rising glucose intolerance, and the
significant pairwise comparisons, a linear regression model was
used to assess CD69 expression according to metabolic status.
Mean CD4+ T cell CD69 expression for non-diabetics, pre-
diabetics, and diabetics is shown in Table 3. Frequencies of
CD69+ cells were natural-log transformed to improve normality
(Shapiro-Wilk p < 0.01 for all untransformed CD4+ and CD8+
T cell subsets). Expression of CD69 on total CD4+ T cells rose
with progressive glucose intolerance (Table 3, p = 0.004), which
was robust to adjustment for BMI (p= 0.03 for metabolic status)
and to age (p = 0.01 for metabolic status) in separate models
(data not shown). Among CD4+ T cell subsets, progression from
non-diabetic to diabetic groups was accompanied by increased
CD69 expression on TCM (p= 0.02), TEM (p= 0.04), and TEMRA
(p= 0.04) cells.
CD57 Expression Is Higher on SAT CD4+
and CD8+ T Cells, but Does Not Vary With
Metabolic Status in PLWH
We previously reported a higher proportion of late-
differentiated, CD57+ CD8+ T cells in the SAT of non-diabetic
PLWH compared to blood (37 vs. 23%, p < 0.01) (21). CD57
is a terminally-sulfated glycan carbohydrate epitope found on
T cells and natural killer (NK) cells which serves as a marker
of late differentiation, though there is limited consensus as
to whether CD57 is a marker of an inability to proliferate in
response to antigen stimulation, signifies reduced replicative
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TABLE 3 | Mean SAT CD4+ and CD8+ T cell CD69 expression according to
glucose tolerance.







Total CD4+ T cells 7.5% 10.9% 17.2% 0.004
CD4 TNAIVE 0.6% 1.1% 2.0% 0.03
CD4 TCENTRAL MEMORY 5.9% 7.8% 11.9% 0.02
CD4 TEFFECTOR MEMORY 14.7% 18.2% 22.3% 0.04
CD4 TEFFECTOR MEMORY RA+ 4.9% 8.9% 7.3% 0.04
Total CD8+ T cells 5.4% 6.2% 10.0% 0.09
TNAIVE 1.5% 0.6% 4.2% 0.28
TCENTRAL MEMORY 6.9% 5.5% 12.8% 0.45
TEFFECTOR MEMORY 11.9% 9.3% 17.0% 0.19
TEFFECTOR MEMORY RA+ 5.0% 5.7% 9.0% 0.12
*Univariable linear regression. The association of total CD4+ T cell CD69 expression with
progressive glucose intolerance was robust to adjustment for BMI (p = 0.03) and to age
(p = 0.01) in separate models.
The bolded values are p-values <0.05, indicating statistical significance.
capacity, or represents an increased susceptibility to activation-
induced apoptosis (42–44). Prior studies have shown that CD57
expression on CD4+ and CD8+ T cells is higher in the blood
of PLWH compared to that of HIV-negative controls (44–46).
CD8+ T cells expressing CD57 produce more interferon-γ
and TNF-α after TCR stimulation than CD57− T cells, and
CD57+ CD8+ T cells have a distinct gene expression profile
characterized by greater cytotoxic effector potential (e.g.,
production of perforin, granzymes, and granulysin) (47, 48).
Additionally, a higher percentage of CD57+ expression on T
cells has been implicated in other inflammatory diseases, such as
rheumatoid arthritis (49) and beryllium-induced disease (50).
Given the potential pro-inflammatory effects of CD57+ T
cells in adipose tissue, we compared CD4+ and CD8+ T cell
expression of CD57 in SAT vs. blood, and according to metabolic
status (Supplementary Figure 11). In all three metabolic groups,
expression of CD57 on SAT CD8+ T cells was higher compared
to blood, confirming our prior study findings (21). Among
the memory subsets, CD57 expression was highest on CD4+
TEMRA and CD8
+ TEM and TEMRA cells. However, we did not
observe an increase in CD57 expression on either CD4+ or
CD8+ memory cell subsets with progressive glucose intolerance,
with the exception of higher CD57 expression on CD4+ TCM in
diabetic individuals compared to those without diabetes.
CD4+CD69lo Cells Co-expressing CD57,
CX3CR1, and GPR56 Are Associated With
Increasing Glucose Intolerance
Adipose tissue serves as a reservoir for both latently HIV-infected
CD4+ T cells and free HIV RNA virus, and in the Genotype-
Tissue Expression (GTEx) project adipose tissue contained one
of the highest levels of CMV transcripts (17, 18, 21, 51). These
findings suggest adipose tissue may also serve as a site for anti-
viral immune activity. Recent studies of CD4+ TEMRA cells have
identified major subsets based on G protein-coupled receptor
GPR56 expression, with virus-specific cells more frequently
GPR56+ and more clonally expanded compared to GPR56− cells
(52). Increased expression of GPR56 and killer-like receptors
(KLR) has been linked to higher cytokine expression by memory
CD4+ T cells, including T cells obtained from liver tissue
(53). CD4+ and CD8+ TEMRA cytotoxic T cells expressing
GPR56 have also been associated with increased co-expression of
CX3CR1 (52, 54, 55). CX3CR1 receptor is expressed on terminally
differentiated T cells, gamma-delta T cells and NK cells, and has
also been identified as a marker of anti-CMV T cells (55–58).
To assess the presence of GPR56+ CX3CR1
+ T cells, and the
parent memory cell population(s), we used t-SNE and viSNE
to identify surface marker clusters that differed between non-
diabetic, pre-diabetic, and diabetic individuals. We identified
a group of cells that expressed CD57, lacked CD69, and also
co-expressed GPR56 and CX3CR1. A representative plot of t-
SNE maps generated from CD4+ gated T cells showed that
the CD57+ CX3CR1
+ GPR56+ co-expression was mainly on
TEM and TEMRA cells (Figure 5A). Concatenated viSNE plots
of non-diabetic, pre-diabetic and diabetic PLWH demonstrated
two distinct clusters of cells: CD57−/+ CD69+ CX3CR1
−/+
GPR56−/+ and CD57+ CD69lo CX3CR1
+ GPR56+ (Figure 5B).
A significantly larger proportion of total CD4+ and CD4+ TEMRA
cells in SAT from diabetics were CD57+ CD69lo CX3CR1
+
GPR56+ compared to SAT from non-diabetics (p = 0.051),
and approached significance for CD4+ TEM cells (p = 0.07)
(Figure 5C). Of note, we observed a similar population of
CD4+ TEMRA and TEM cells co-expressing CD57
+ CX3CR1
+
GPR56+ in matched PBMC samples which, again, increased
with glucose intolerance and were significantly different between
diabetic and non-diabetic PLWH (total CD4+ [p < 0.01],
CD4+ TEM [p = 0.05] and CD4
+ TEMRA [p < 0.05])
(Supplementary Figure 6). Similar plots of CD8+ T cells were
generated for adipose tissue (Supplementary Figure 7) and
PBMC (data not shown) from PLWH. As with the CD4+ T cells,
CD57+ CX3CR1
+ GPR56+ co-expressing CD8+ T cells were
predominantly TEM and TEMRA, though there were no significant
differences between non-diabetics and diabetics.
Lastly, we assessed CD57+ CX3CR1
+ GPR56+ co-expression
on SAT CD4+ and CD8+ T cells from our HIV-negative controls
(Supplementary Figure 8). We identified two distinct clusters of
CD4+ and CD8+ TEM and TEMRA cells co-expressing CD57,
CX3CR1, and GPR56 though the expression was more diffuse
compared to SAT cells from PLWH, particularly for GPR56.
Taken together, our results demonstrate a population of
CD57+CX3CR1
+GPR56+ co-expressing predominantly CD4+
TEMRA cells in both blood and SAT of PLWH which appear
to be associated with diabetes. The expression of the GPR56
and CX3CR1 markers may indicate these cells are virus-specific
TEMRA cells, a population that could contribute to inflammation
in adipose tissue.
SAT CD4+ and CD8+ T Cell Memory
Subsets Compared by HIV Status
Couturier et al. identified a major shift in the CD4:CD8T
cell ratio in PLWH compared to HIV-negative controls (17),
a finding that has been replicated in subsequent HIV and SIV
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FIGURE 5 | CD4+ T cells co-expressing CD57, CX3CR1, GPR56 in subcutaneous adipose tissue increase with progressive glucose intolerance. viSNE plots were
generated in cytobank to identify groups of cells that differ between non-diabetic, pre-diabetic and diabetic categories. (A) Clusters of CD4+, TNai, TEM, TCM, and
TEMRA cells from subcutaneous adipose tissue (SAT). (B) Concatenated viSNE plots of non-diabetic, pre-diabetic, and diabetic PLWH showing clusters of cells
expressing CX3CR1, CD57, GPR56, and CD69. (C) Violin plots showing percentage of total CD4
+, TEM, and TEMRA cells co-expressing CD57, CX3CR1, and
GPR56. Mann-Whitney test used to analyze differences between metabolic groups; *P < 0.05.
studies (18, 19, 21). Specifically, adipose tissue stromal vascular
fraction (SVF) CD3+ T cells from individuals without HIV were
predominantly memory CD4+ CD45RO+ T cells rather than
memory CD8+ T cells. In contrast, this distribution was reversed
in PLWH, with more memory CD8+ T cells in the adipose tissue,
which represented an ∼50% enrichment in memory CD8+ T
cells over the peripheral blood, and could not be attributed to
differences in peripheral blood T cell subsets
Phenotypic analysis of SAT memory T cell subsets in PLWH
could provide insight on possible mechanisms contributing to
the profound shift in the CD4:CD8 ratio that accompanies HIV
infection. Therefore, we compared the proportion of CD4+ and
CD8+ naive, TCM, TEM, and TEMRA cells between 8 non- and
pre-diabetic HIV-negative persons and 9 PLWH; these subjects
were selected from the 26 PLWH in our cohort based on similar
age, HbA1c and BMI values (Table 2). As in prior studies, we
found that SAT from PLWH is enriched in CD8+ T over CD4+
T cells (51 vs. 47%, respectively) compared to HIV-negative
persons (21 vs. 66%; Figures 6A,D). Although PLWH have a
much higher proportion of CD8+ T cells in the SAT, we found
no significant difference in the overall proportions of SAT CD4+
and CD8+ memory cells between PLWH and HIV-negative
persons (Figures 6C,F), and the distribution of CD4+ and CD8+
memory T cell subsets was remarkably similar (Figures 6B,E).
However, three notable differences were present: compared to
PLWH, the HIV-negative persons had a significantly higher
percentage of CD4+ TEM (58 vs. 39%, p = 0.02), a lower
percentage of CD4+ TCM (15 vs. 29%, p = 0.07) in their SAT
(Figure 6B), and a significantly higher percentage of CD8+ TCM
compared to PLWH (6.4 vs. 3.4%, p= 0.03) (Figure 6E).
These findings suggest the profound change in the SAT
CD4:CD8T cell ratio observed in PLWH is not driven by the
enrichment or depletion of a single memory T cell phenotype.
Rather, it is phenotype agnostic and involves shifts in disparate
naïve and memory T cell phenotypes from both the CD4+ and
CD8+ lineages. This raises the possibility that a chemotactic
signal from SAT in PLWH is recruiting CD8+ T cells more
robustly in the context of infection with HIV. However, the
similar subset distributions suggest this signal, if present, may
represent the amplification of a normal physiologic pathway as
opposed to an “HIV-specific” process.
Comparison of SAT Gene Expression in
PLWH and HIV-Negative People With
Similar Glucose Tolerance
Given the increased proportion of CD8+ T cells in SAT from
PLWH, we performed a sub-study to investigate potentially
relevant adipose tissue immune signaling pathways upregulated
in the context of HIV infection. Extracted SAT mRNA from
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FIGURE 6 | Comparison of CD4+ and CD8+ T cell subsets in subcutaneous adipose tissue of PLWH and matched HIV-negative controls. Cells recovered from
subcutaneous adipose tissue (SAT) of PLWH (n = 9) and HIV-negative controls (n = 8) with similar BMI and hemoglobin A1c were compared. (A) CD4+ T cells as a
percentage of total live CD3+ T cells. (B) Frequencies of TNai, TEM, TCM, and TEMRA cells in SAT of PLWH and HIV-negative controls. (C) Total CD4
+ memory T cells
(TCM + TEM + TEMRA ). (D) Similar analysis also done on CD8
+ T cells, which are displayed as percentage of total live CD3+ T cells. (E) Frequencies of CD8+ TNai,
TEM, TCM, and TEMRA cells. (F) Total CD8
+ memory T cells. The box and whiskers plot indicate mean ± SD. Mann-Whitney test used to analyze differences between
unpaired PLWH and (–) subjects; **p < 0.01, *p < 0.05.
6 PLWH and 7 HIV-negative individuals was assayed using a
NanoString human inflammation panel to quantitate expression
of over 250 genes representing a broad range of immune
pathways (Figure 7A). The overall fold change in genes expressed
from SAT of PLWH over HIV-negative is shown in the volcano
plot (Figure 7B). In general, we found increased expression of
chemokine receptors (CXCR2, CXCR1, CXCR4) and ligands
(CCL5, CXCL5) in those with HIV. Additional genes including
ALOX12 and IL12A were also elevated. We further analyzed
inflammatory gene pathways defined by NanoString (Figure 7C).
CXCR2, CXCR1, CXCR4, TLR2, and TLR8 gene expression
were significantly higher in PLWH compared to HIV-negative
(Table 4) whereas CD4 and CXCL9 were higher in HIV-
negative individuals. Future studies are needed to identify the
cells expressing these genes, and whether receptor and ligand
expression might account for differences in the cells that traffic
to SAT in PLWH.
DISCUSSION
Several recent studies have uncovered a profound change in the
balance of adipose tissue CD8+ and CD4+ T cells in PLWH, and
similar studies in SIV-infected macaques indicate that the relative
enrichment of CD8+ T cells stems from viral infection rather
than from ART treatment or CD4+ cell depletion. However, the
characteristics and consequences of this CD8+ cell enrichment
are generally unknown. Here, we demonstrate that the adipose
tissue of PLWH with viral suppression on long-term ART is a
reservoir of CD4+ and CD8+ TEM and TEMRA cells; two cell
types with high pro-inflammatory potential when stimulated.
Furthermore, we show that expression of CD69, a putative
marker of TCR-linked activation and tissue residency, increased
on CD4+ TEM and TEMRA cells in a stepwise manner from
non-diabetic, to pre-diabetic, to diabetic individuals. We also
identify a phenotypically unique population of CD4+ T cells
co-expressing CX3CR1, GPR56, and CD57 that is specifically
enriched in the SAT of diabetic PLWH. While the significance
of these cells is currently unclear, CX3CR1 and GPR56 have
previously been identified on cells with antiviral functions (55–
59). Finally, our results demonstrate that the enrichment of
CD8+ T cells over CD4+ T cells in PLWH as compared to HIV-
negative individuals is relatively non-specific in the sense that the
change is not attributable to a profound increase or reduction in
a single memory cell subset.
Our findings contribute to the growing body of literature on
both adipose tissue T cells in general, as well as the immune
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FIGURE 7 | PLWH have a higher CXCR1, CXCR2, CXCR4, CCL5, CXCL5, TLR2, and TLR8 RNA expression within the subcutaneous adipose tissue compared to
HIV negative individuals with similar glucose tolerance. RNA was extracted from subcutaneous adipose tissue of PLWH (n = 6) and HIV negative individuals (n = 7).
(A) Schematic showing data analysis. (B) Volcano plot showing log2 fold change (PLWH vs. HIV negative) vs. log10 p-value. Relevant genes out of 249 genes are
labeled. (C) Sub-groups of inflammatory gene panels available through Nanostring were compared and adjusted p-values calculated within these groups. Genes in
G-alpha signaling, defensins and Toll-like receptors with significant findings are shown. Red denotes genes that are higher in PLWH and blue denotes higher gene
expression in HIV negative.
phenotype of adipose tissue in the context of metabolic disease
among PLWH. Han et al. recently demonstrated that white
adipose tissue in mice is a major reservoir for memory T cells
with potent proliferative, effector, and protective potential (39).
The adipose tissue T cells predominantly expressed CD44, a
marker of antigen experience, and were CD62L negative, which is
consistent with TEM and TRM populations in mice. Furthermore,
approximately half the CD44+CD62L− CD8+ and CD4+ cells
expressed CD69. The study also assessed recall responses of
adipose tissue T cells in mice previously challenged with antigen,
demonstrating an influx of monocytes and neutrophils, as well
as highly reactive memory T cells. Specifically, these memory
T cells indicated rapid and enhanced effector potential with
upregulation of several genes involved in antimicrobial defenses.
Furthermore, antigen re-challenge led to downregulation of
several metabolic pathways (including lipid biosynthesis and
cholesterol and long-chain fatty-acyl-CoA metabolic processes)
as well as to a detectable reduction in serum levels of adiponectin
and cholesterol, further highlighting the potential role memory T
cells play in metabolic disease.
These animal studies suggest the accumulation of TEM and
TEMRA cells in the adipose tissue of PLWH may represent
a potent source of inflammation in the setting of antigen
stimulation. Viral pathogens, including HIV and CMV, are found
in adipose tissue and could serve as a chronic stimulus for
TEM and TEMRA cells, with downstream effects on metabolic
function (17, 21, 39, 51). Our observation of increasing TEM
and TEMRA CD69 expression with declining glucose tolerance
in PLWH may indicate the enrichment of a resident memory
phenotype in diabetic individuals. Our study design precludes
an assessment of whether the presence of increased CD69+
TEM and TEMRA cells preceded or followed the development of
glucose intolerance, though future longitudinal studies in PLWH
with early indications of metabolic disease could address this
question. Furthermore, future studies to identify the receptor
specificity of the CX3CR1, GPR56, and CD57-expressing CD4
+
cells, and experiments to co-culture these cells with adipocytes,
may help characterize the role of these immune cells in adipose
tissue, identify their cytokine expression patterns, and explore the
potential effects of these cells on adipocyte function.
An early study of SAT and VAT from PLWH by Couturier
et al. identified major differences in CD4+ and CD8+ T cell
populations compared to HIV-negative controls (17), which were
subsequently reported in other HIV and SIV studies (18, 19,
21). In the HIV-negative controls, adipose tissue SVF CD3+
T cells in SAT were predominantly memory CD4+ CD45RO+
T cells (61%) with fewer memory CD8+ T cells (15%), while
this distribution was reversed in PLWH, with more memory
CD8+ T cells (46%) compared to memory CD4+ T cells (35%).
This represented an ∼50% enrichment in memory CD8+ T cells
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TABLE 4 | RNA gene expression in SAT of PLWH compared to HIV-negative.
Fold change PLWH over HIV negative
Base mean log2Fold
change
lfcSE stat P-value P-adj
GENES IN G ALPHA (I) SIGNALING EVENTS
CXCR2 448.38936 1.66765 0.40295 4.13858 0.00003 0.00077
CXCL9 318.40348 −1.02425 0.29993 −3.41498 0.00064 0.00702
CXCR1 64.4378 2.32789 0.74234 3.13589 0.00171 0.01256
CXCR4 614.54675 0.62417 0.22333 2.79483 0.00519 0.02856
CCR7 52.79557 1.03026 0.38811 2.65456 0.00794 0.03494
CCL5 693.45461 0.79026 0.30909 2.55671 0.01057 0.03875
GENES IN DEFENSINS
CD4 429.29116 −0.70372 0.19864 −3.54278 0.0004 0.00198
TLR2 285.1579 0.37392 0.15213 2.45786 0.01398 0.03494
GENES IN TOLL LIKE RECEPTORS
TLR2 301.23122 0.71396 0.21186 3.37002 0.00075 0.03007
TLR8 199.60192 0.6878 0.22039 3.12083 0.0018 0.03607
GENES IN DISEASE
TLR2 302.33202 0.7476 0.20994 3.561 0.00037 0.01034
CXCR4 618.19156 0.72581 0.21895 3.31492 0.00092 0.01283
over the blood in the subjects with HIV and was not reflective
of differences in peripheral blood T cell subsets between the
two groups.
Notably, the Couturier et al. study found significant
differences in the rates of CD69 expression on memory CD4+
and CD8+ T cells in adipose tissue vs. blood: <5% of these
cells expressed CD69 in the blood, compared to 60–67% in
adipose from PLWH and 61–72% in the adipose from HIV
negative persons. A similar study comparing activation markers
on adipose tissue T cells in HIV-negative lean, overweight and
obese individuals using fine needle aspiration found ∼5–10%
CD69 expression on SAT CD4+ T cells and∼25% expression on
CD8+ T cells (60). We observed the highest CD69 expression on
TEM cells in diabetic PLWH (mean 22%). This was significantly
higher than CD69 expression on TEM cells from non-diabetics
(mean 15%) and pre-diabetics (mean 18%), and 20-fold higher
compared to TEM cells in blood. The reason for the lower CD69
expression in our cohort compared to Couturier et al. is unclear
and may reflect differences in CD69 expression in adipose tissue
samples collected after death or by surgical resection as opposed
to liposuction aspirates processed within 30–60min of collection
in our study, differences in tissue processing to extract T cells,
or could be explained by residual peripheral blood in samples
obtained via liposuction.
Prior studies have also demonstrated a significantly higher
proportion of SAT Treg cells (defined as CD25+ FOXP3+
CD4+ T cells; a cell type thought to exert an anti-inflammatory
effect and reported to be depleted in obese adipose tissue)
in PLWH compared to HIV-negative persons, with no major
differences in TH1 and TH17 pro-inflammatory subsets (19, 24).
The proportion of TH1 CD4
+ T cells (expressing intermediate or
high levels of T-bet) did not differ according to HIV status, while
TH2 CD4
+ T cells (expressing GATA-3) were barely detected in
the adipose tissue from both PLWH and HIV-negative persons.
While CD4+ T cell expression of HLA-DR (24%) in SAT was
higher compared to blood in the HIV-negative, similar levels
of SAT HLA-DR expression were observed in the PLWH.
Furthermore, SAT CD4+ T cell expression of PD-1 expression
was much higher compared to PBMCs (45 vs. 3%), but again
there were no significant differences in SAT according to HIV
status (19).
Two studies of SIV-infected cynomolgus macaques confirm
the adipose tissue CD8+ T cell enrichment observed in PLWH
is a viral phenomenon, rather than related to ART treatment (18,
61). In both studies, SIV infection was associated with a higher
percentage of CD8+ T cells in both the SAT and VAT compared
to non-infected animals (18, 61). One study also demonstrated
the inverted CD8:CD4 ratio was not driven by a reduction in the
total number of CD4+ T cells in infected animals; rather, SIV-
infected animals had significantly higher density of CD8+ T cells
in VAT and a somewhat higher density in SAT (18). For both
non-infected healthy and SIV-infected monkeys, the majority of
the adipose tissue CD4+ and CD8+ T cells were memory T cells
(>94% CD95+), with a large fraction of activated cells marked by
expression of CD69+ (62–84%) and CD25+ (3–13%).
A central question that remains unanswered is whether
the increase in the proportion of adipose tissue CD8+ T
cells in PLWH and macaques with SIV results from in situ
proliferation vs. increased infiltration from the circulation. The
high expression of CD69 on SAT memory cells suggests a “tissue
resident” phenotype, but does not answer the question of whether
these cells are expanded clones or prior migrants. On the one
hand, a study by Damouche et al. found no significant differences
in the proportion of CD4+ or CD8+ T cells expressing Ki-67,
indicative of cycling and recently divided cells, between PLWH
vs. HIV-negative controls (19). The authors suggested the low
percentage of Ki-67+ cells in SAT (<2%) from PLWH and HIV-
negative subjects reflected minimal T cell proliferation within
the tissue. Similarly, a study in macaques found no differences
in proportions of Ki-67-expressing CD4+ or CD8+ T cells in
animals with and without SIV, suggesting the higher density
of CD8+ T cells in adipose tissue does not result from recent
proliferation (18). However, proliferation of memory T cells
within adipose tissue is clearly demonstrated in other studies.
Han et al. injected mice with pseudotuberculosis and evaluated
memory T cells 4 weeks later. They showed proliferation of TEM
and TRM by Ki67 expression, bromodeoxyuridine labeling, and
cell cycle stage analysis of memory T cells (39).
The use of T cell receptor (TCR) sequencing of adipose
tissue T cell subsets in future studies may provide insight into
the clonal lineage of adipose tissue T cells. Previously, our
group demonstrated that CD8+ TCR clonality is higher in SAT
compared to blood in PLWH using bulk TCRβ CDR3 deep
sequencing, where bias-controlled V and J gene primers are used
to amplify rearranged V(D)J segments (21, 62, 63). In that study,
the 10 most prevalent TCRβ clones comprised a significantly
larger percentage of total clones in SAT (25%) compared to paired
blood (16%), and the Shannon’s Entropy index, a measure of
overall repertoire diversity, was lower in adipose tissue compared
to blood (4.39 vs. 4.46, respectively). Additionally, V-J gene
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pairing and gene usage differed between blood and adipose
tissue, albeit not statistically significant, potentially due to the
small sample size. While these findings are intriguing, the lower
proportion of CD4+ and CD8+ TNai cells in SAT demonstrated
in the current analysis may have had a role in the higher SAT
clonality scores reported in the prior study. In addition to clonal
lineage, TCR sequencing may also inform our understanding of
potential antigen targets for adipose tissue T cells in PLWH.
A recent study in mice demonstrated that diet-induced obesity
is characterized by increased adipose tissue CD8+ T cell
density, and the TCR repertoire of these CD8+ T cells is more
clonal and positively charged (in respect to amino acids). This
work was also the first to demonstrate that isolevuglandins
(a group of negatively charged reactive gamma-ketoaldehydes
generated by free radical oxidation) presented on adipose
tissue macrophages from obese fat can independently activate
T cells, potentially highlighting a mechanism contributing to
inflammation (25). Examining TCR charge and polarity, in
addition to clonality, and investigating antigen presenting cells
in the adipose tissue may be an important approach for further
characterizing the adipose tissue immune milieu in PLWH vs.
HIV-negative persons.
Profiling of adipose tissue mRNA expression in SIV-infected
macaques showed significantly higher levels of IL-2, IL-7, and
CCL19 in acute SIV compared to uninfected controls, which may
contribute to the homing and survival of T cells (61). In our gene
expression sub-study on whole adipose tissue of PLWH andHIV-
negative controls with similar glucose tolerance, we found >2-
fold expression of IL12A, CXCR1, CXCL5, ALOX12, and C9 in
the PLWH compared to HIV-negative. Analysis of subgroups of
inflammatory gene pathways revealed significantly higher levels
of TLR2, TLR8, CXCR4, CCR7, CCL5, CXCR1, and CXCR2 and
lower levels of CXCL9 and CD4 in the PLWH.
Previous studies have linked inducible and increased
expression of TLR2 in PBMC and SAT of obese individuals
with type 2 diabetes (64–67). TLR8 is an endosomal receptor
that binds HIV-1 single-stranded RNA and is similar to TLR2
in its MyD88-dependent activation of NF-kB. Previous studies
of TLR8 expression indicate that it is most often absent or
present at low levels in adipose tissue (64), but that a positive
correlation exists between plasma CRP levels and adipose tissue
TLR8 expression. In our study, we are unable to discriminate
whether the differences in TLR expression are due to alterations
on T cells, macrophages, adipocytes or pre-adipocytes. However,
we likely have identified a contribution of TLR8 to SAT
inflammation that is more pronounced in PLWH compared
to HIV-negative individuals with similar glucose tolerance
and BMI.
Regarding chemokine ligands and receptors, M1macrophages
express higher levels of CCR7, CCL9, and CCL5 and lower levels
of CXCR4 in comparison toM2macrophages (68). In the context
of HIV infection, CXCR1 and CXCR2 are of interest because
HIV-1 matrix protein p17 has been shown to mimic IL-8 and
binds CXCR2 with high affinity, stimulating pro-angiogenic ERK
downstream (69). Angiogenesis has been linked to obesity via
neovascularization-driven migration of adipocytes (70). Further
studies of chemokine receptors on CD4+ and CD8+ T cells may
provide insight into whether HIV infection results in signals
that preferentially recruit CD8+ T cells over CD4+ T cells
independent of obesity.
LIMITATIONS
Our cohort study was cross-sectional and enrolled a total of
34 participants. We classified participants as non-diabetic and
pre-diabetic based on fasting blood glucose and HbA1c values
as recommended for clinical practice by the American Diabetes
Association (diabetics were classified based on medication
usage). In the future, the measurement of fasting insulin and
use of the homeostatic model assessment (HOMA) may provide
more nuanced stratification of participants. While a strength of
our study was the collection of SAT via liposuction and rapid
processing to extract T cells, samplesmay have contained residual
peripheral blood, which would bias our comparisons of SAT and
blood toward the null hypothesis. We were limited in the number
of markers we could examine via flow cytometry and did not
examine additional markers of tissue resident cells, as well as
T regulatory cells and TH1/TH2 subsets. Our gene expression
analysis of SAT from PLWH and HIV-negative persons was on
whole adipose tissue as opposed to sorted SVF cells. Therefore,
differences in genes cannot be directly linked to specific cell types.
CONCLUSIONS
Although PLWH can survive decades on effective ART, this
success is offset by the rising burden of metabolic diseases
affecting the HIV population (1–3). Here, we demonstrate that
the adipose tissue of PLWH is a reservoir of CD4+ and CD8+
TEM and TEMRA cells; two cell types with high pro-inflammatory
potential when stimulated. Furthermore, we show that expression
of CD69, a putative marker of TCR-linked activation and tissue
residence, on CD4+ T cells increases in a stepwise manner
from non-diabetic, to pre-diabetic, to diabetic individuals, which
may reflect an interaction between cells of the adaptive immune
system and adipocytes in the context of metabolic disease.
We also identify a population of CD57+CX3CR1
+GPR56+ co-
expressing CD4+ T cells that is specifically enriched in the SAT
of diabetics. This could represent a group of virus-specific cells
that contribute to inflammation in adipose tissue and potentially
pre-dispose PLWH to metabolic disease, though further studies
to assess the effects of these cells on adipocytes are needed.
Finally, our results demonstrate that the enrichment of CD8+
T cells over CD4+ T cells in PLWH as compared to HIV-
negative individuals is relatively non-specific in the sense that the
change is not attributable to a profound increase or reduction
in a single memory cell subset. Further studies are needed
to understand the clonal lineage, TCR characteristics, antigen
targets, chemokine receptors and the functional phenotype of
CD57+CX3CR1
+GPR56+ T cells in the adipose tissue of PLWH,
and to identify potential therapeutic targets.
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